Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yogourmet is a specialized brand of probiotic and fermentation starters manufactured by Lyo-San, a Canadian biotechnology company and subsidiary of Lallemand. The company focuses on the production of high-quality, freeze-dried cultures for yogurt and kefir, designed for both consumer and professional use. Their products are engineered to provide high concentrations of beneficial bacteria, such as Lactobacillus bulgaricus and Streptococcus thermophilus, to support gut health and microbiome diversity. Yogourmet is widely recognized for its role in therapeutic nutrition, particularly within the Specific Carbohydrate Diet (SCD) community. By leveraging the global manufacturing and R&D capabilities of Lallemand Health Solutions, Yogourmet continues to innovate in the field of live biotherapeutics and functional foods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yogourmet.